Mandate

Nordstjernan invests in Mama Mia

December 20, 2017 M&A

Vinge has advised Nordstjernan in conjunction with the acquisition of the majority of shares in Barnmorskegruppen MAMA MIA Aktiebolag (”Mama Mia”), as a supplementary acquisition to Lideta Hälsovård.

Mama Mia conducts prenatal and childcare services at seven units in Stockholm and Malmö, as well as primary care at two units in Stockholm under the trademark, To Care. The company has grown quickly over the last few years and during the last financial year its turnover was approximately MSEK 200 with approximately 170 employees.

Vinge’s team consisted of Johan Winnerblad, Kristina Ekberg, Samra Baytar, Josephine Andersson, Martin Boström, Frida Ställborn and Mikaela Lang.
 

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025